Improving Outcomes in Heart Failure – Focus on Guideline Adherence and Comorbidities

Published: 29 September 2020

  • Views:

    Views Icon 265

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

In this series from the e-SPACE Heart Failure Global Web-Conference, Ileana Piña, Peter van der Meer and Stefan Anker discuss improving outcomes in heart failure with a focus on guideline adherence and comorbidities.

Organised by MedEd Global Solutions and supported by an unrestricted grant from Vifor Pharma

Educational objectives

  • Review Pharmacological Treatments That Reduce Mortality and Hospitalisations in Patients With Heart Failure
  • Evaluate Adherence to Heart Failure Management Guidelines and Barriers to Optimal Use of Guideline-Recommended Therapy
  • Recognise the Importance of Integrated Care of Comorbidities in the Management of Heart Failure Patients
  • Assess the Role of Novel Potassium Binders in Optimising Optimal Renin–Angiotensin– Aldosterone System Inhibitor (RAASi) Therapy in Patients With Heart Failure
  • Review the Benefits of Treating Iron Deficiency in Heart Failure With Respect to Functional Capacity and Symptomatic Improvement

Symposium Agenda

  • Time - Session title and Objective - Speaker(s)
  • 20 mins - Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization - Ileana L. Piña, Detroit, MI, USA
  • 20 mins - Optimising RAASi Therapy Through Long-Term Potassium Control - Javed Butler, Atlanta, GA, USA
  • 20 mins - Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life - Peter van der Meer, Groningen, The Netherlands
  • 25 mins - Interactive Panel Discussion - Stefan Anker & Javed Butler

More from this programme

Part 1

Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization

1 session
Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization Watch now

Part 2

Optimising RAASi Therapy Through Long-Term Potassium Control

1 session
Optimising RAASi Therapy Through Long-Term Potassium Control Watch now

Part 3

Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life

1 session
Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life Watch now

Part 4

Panel Discussion

1 session
Panel Discussion Watch now

Faculty Biographies

Peter van der Meer

Peter van der Meer

Cardiologist

Prof Peter van der Meer is a Cardiologist at University Medical Centre Groningen, Groningen, NL.

Prof van der Meer has a focus on heart failure and cardiac devices. He is a member of the ESC council of cardio-oncology, member of the working group on translational cardiology and peripartum cardiomyopathy of the ESC and associate editor of the European Journal of Heart Failure.

View full profile